The UK’s Competition and Markets Authority (CMA) has launched a call for evidence seeking feedback on its approach to merger remedies. This is one of a number of initiatives that signal a shift towards what is intended to be...more
Many commentators believe that roll-up and other add-on transaction strategies will continue to be attractive to private equity fund managers across global markets. Competition authorities in the UK, Europe and the US have...more
The UK Competition and Markets Authority (“CMA”) has published an “Update Paper” outlining its evolving views on AI foundation models as well as its approach to supporting Government consideration on possible regulation. This...more
On 25 April 2023, the UK Government published the long-awaited draft Digital Markets, Competition and Consumers Bill (the “Bill”). The Bill will introduce a broad range of reforms (including in respect of competition and...more
An EU Advocate General has advised that an appeal brought by Altice should be dismissed in its entirety – in effect confirming the validity of a 2018 European Commission decision imposing a record fine on Altice for breaching...more
On 25 April 2023, the Government published the long-anticipated draft Digital Markets, Competition and Consumers Bill (the Bill), consolidating the results of two consultations launched in July 2021. If enacted, the Bill will...more
New measures, announced on 21 June 2020, will allow the UK Government to intervene in relation to transactions involving businesses with "critical capabilities" to help combat public health emergencies, such as...more
Read the latest news on antitrust, competition, and economic regulation in this summer edition of our quarterly ACER newsletter.
...more
9/19/2018
/ Algorithms ,
Anti-Competitive ,
Anti-Steering Rules ,
Antitrust Provisions ,
Antitrust Violations ,
AT&T ,
China ,
Competition ,
Competition Act ,
EU ,
Excessive Pricing ,
False Advertising ,
Foreign Investment ,
Internet Retailers ,
Legislative Agendas ,
Merger Controls ,
Monopolization ,
National Health Service Corp (NHSC) ,
Ohio v American Express ,
Pfizer ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Standards ,
SCOTUS ,
Single Entity Rule ,
Telecommunications ,
Time Warner ,
UK ,
UK Competition and Markets Authority (CMA) ,
UK Competition Appeal Tribunal (CAT) ,
Unfair or Deceptive Trade Practices